Umbralisib
Umbralisib (TGR-1202) is a selective small molecule inhibitor of the delta isoform of phosphoinositide 3-kinase (PI3Kδ) . It is utilized in preclinical research for studying hematological malignancies, demonstrating activity in both in vitro cellular assays and in vivo models of B-cell lymphomas.
Product Specifications
CAS Number
1532533-67-7
Product Name Alternative
RP 5264, RP5264, RP-5264, TGR 1202, TGR1202, TGR-1202, PI3Kδ, PI3K, Phosphoinositide 3-kinase, Umbralisib, inhibit, orally active, lymphoma, lymphocytic leukemia, Inhibitor, haematological malignancies, cancer, Casein Kinase, CLL T cells
Field of Research
Metabolism Research, Pharmacology & Drug Discovery, Signal Transduction, Stem Cell & Developmental Biology
Purity
99.56% (May vary between batches)
Solubility
10% DMSO+90% Corn Oil:3.3 mg/mL (5.77 mM) ; DMSO:91 mg/mL (159.22 mM)
Smiles
CC (C) Oc1ccc (cc1F) -c1nn ([C@@H] (C) c2oc3ccc (F) cc3c (=O) c2-c2cccc (F) c2) c2ncnc (N) c12
Molecular Formula
C31H24F3N5O3
Molecular Weight
571.55
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
